Hepatocellular foci--a regulator's Gordian

Area of Science:

• Toxicology
• Hepatopathology
• Regulatory Science

Background:

• Increased incidence of hepatocellular alteration foci observed in treated rats.
• Pathologists play a crucial role in diagnosing liver lesions and assessing their biological significance.
• Regulatory agencies like the Food and Drug Administration (FDA) evaluate these findings.

Purpose of the Study:

• To address the significance of increased hepatocellular alteration foci in rats.
• To clarify the role of study pathologists in evaluating liver lesions.
• To inform regulatory review processes for petitions involving liver pathology.

Main Methods:

• Pathological assessment of liver tissues from treated rats.
• Review of diagnostic criteria for proliferative liver changes.
• Evaluation of historical control data for incidence comparisons.

Main Results:

• Current observations suggest a higher incidence of hepatocellular alteration foci than historical controls.
• The progression of these foci to neoplastic lesions is variable and not definitively predictable.
• Direct correlation between foci incidence and carcinogenic activity is not yet established.

Conclusions:

• The biological significance of hepatocellular alteration foci requires careful pathological appraisal.
• Predicting carcinogenic potential solely based on foci incidence is not currently possible.
• The FDA will continue to evaluate proliferative liver lesions, including foci of cellular alteration, on a case-by-case basis.